MORPHINE SULFATE INJECTION, USP

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: f2d182cc0aa31029
Drug Approval Canada Name: MORPHINE SULFATE INJECTION, USP
Product Name: MORPHINE SULFATE INJECTION, USP
Status: Marketed
Status Date: 2019-12-17
Original Market Date: 2019-12-17
Din: 02482746
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intramuscular , Intravenous , Subcutaneous
Schedule: Narcotic (CDSA I)
Ahfs: 28:08.08
Atc Original: N02AA01 MORPHINE
Atc Name: n 02 aa 01
Aig Number: 0104545001
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

MORPHINE SULFATE

10 MG / 1 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f2d182cc0aa31029

Type

Standard